EurekAlert! -- SCOTTSDALE, Ariz. (Sept. 22, 2009) – TGen Clinical Research Services at Scottsdale Healthcare today announced the start of a clinical trial for a drug designed to combat adrenocortical carcinoma (ACC), a rare but deadly cancer that attacks the adrenal glands.
